OMEROS CORP Increase (Decrease) in Receivables
OMEROS CORP (OMER) reported Increase (Decrease) in Receivables of $10.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2026-08-12
- OMEROS CORP increase (decrease) in receivables for the quarter ending 2026-06-30 was $9.27M.
- OMEROS CORP increase (decrease) in receivables for the quarter ending 2026-03-31 was $1.11M.
- OMEROS CORP increase (decrease) in receivables for the quarter ending 2025-12-31 was $4.01M, a 179.76% increase year-over-year.
- OMEROS CORP increase (decrease) in receivables for the quarter ending 2025-09-30 was $632.00K.
- OMEROS CORP increase (decrease) in receivables for fiscal 2025 was $3.18M.
- OMEROS CORP increase (decrease) in receivables for fiscal 2024 was -$357.00K.
- OMEROS CORP increase (decrease) in receivables for fiscal 2023 was -$205.13M, a 217.17% decline from fiscal 2022.
- OMEROS CORP increase (decrease) in receivables for fiscal 2022 was $175.07M, a 410.19% increase from fiscal 2021.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 9 month as first filed | Increase (Decrease) in Receivables 12 month | Increase (Decrease) in Receivables 204 month | Increase (Decrease) in Receivables 207 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $9.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $10.38M 10-Q · filed 2026-08-12 | $14.39M derived: sum of 3 quarters · filed 2026-08-12 | $15.03M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2026-03-31 | $1.11M 10-Q · filed 2026-05-13 | $5.12M derived: sum of 2 quarters · filed 2026-05-13 | $5.76M derived: sum of 3 quarters · filed 2026-05-13 | $4.96M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-12-31 | $4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.64M derived: sum of 2 quarters · filed 2026-03-31 | $3.84M derived: sum of 3 quarters · filed 2026-08-12 | $3.18M 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $632.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$168.00K derived: sum of 2 quarters · filed 2026-08-12 | -$831.00K 10-Q · filed 2025-11-13 | $602.00K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-06-30 | -$800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$1.46M 10-Q · filed 2026-08-12 | -$30.00K derived: sum of 3 quarters · filed 2026-08-12 | -$1.80M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-03-31 | -$663.00K 10-Q · filed 2026-05-13 | $770.00K derived: sum of 2 quarters · filed 2026-05-13 | -$1.00M derived: sum of 3 quarters · filed 2026-05-13 | -$566.00K derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$341.00K derived: sum of 2 quarters · filed 2026-03-31 | $97.00K derived: sum of 3 quarters · filed 2026-03-31 | -$357.00K 10-K · filed 2026-03-31 | |||
| 2024-09-30 | -$1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.34M derived: sum of 2 quarters · filed 2025-11-13 | -$1.79M 10-Q · filed 2025-11-13 | -$1.70M 10-Q · filed 2024-11-13 | -$572.00K derived: sum of 4 quarters · filed 2026-03-31 | ||
| 2024-06-30 | $438.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$16.00K 10-Q · filed 2025-08-14 | $1.20M derived: sum of 3 quarters · filed 2026-03-31 | -$3.11M derived: sum of 4 quarters · filed 2026-03-31 | |||
| 2024-03-31 | -$454.00K 10-Q · filed 2025-05-15 | $764.00K derived: sum of 2 quarters · filed 2026-03-31 | -$3.55M derived: sum of 3 quarters · filed 2026-03-31 | -$2.39M derived: sum of 4 quarters · filed 2026-03-31 | |||
| 2023-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$3.09M derived: sum of 2 quarters · filed 2026-03-31 | -$1.94M derived: sum of 3 quarters · filed 2026-03-31 | -$205.13M 10-K · filed 2026-03-31 | |||
| 2023-09-30 | -$4.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$3.15M derived: sum of 2 quarters · filed 2024-11-13 | -$206.34M 10-Q · filed 2024-11-13 | -$6.98M derived: sum of 4 quarters · filed 2025-03-31 | |||
| 2023-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$202.03M 10-Q · filed 2024-08-07 | -$2.66M derived: sum of 3 quarters · filed 2025-03-31 | -$3.29M derived: sum of 4 quarters · filed 2025-03-31 | |||
| 2023-03-31 | -$203.19M 10-Q · filed 2024-05-15 | -$3.82M derived: sum of 2 quarters · filed 2025-03-31 | -$4.45M derived: sum of 3 quarters · filed 2025-03-31 | -$6.22M derived: sum of 4 quarters · filed 2025-03-31 | |||
| 2022-12-31 | $199.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $198.74M derived: sum of 2 quarters · filed 2025-03-31 | $196.97M derived: sum of 3 quarters · filed 2025-03-31 | $175.07M 10-K · filed 2025-03-31 | |||
| 2022-09-30 | -$625.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$2.40M derived: sum of 2 quarters · filed 2023-11-09 | -$24.30M 10-Q · filed 2023-11-09 | -$20.04M derived: sum of 4 quarters · filed 2024-04-01 | |||
| 2022-06-30 | -$1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$23.68M 10-Q · filed 2023-08-09 | -$19.42M derived: sum of 3 quarters · filed 2024-04-01 | -$17.36M derived: sum of 4 quarters · filed 2024-04-01 | |||
| 2022-03-31 | -$21.90M 10-Q · filed 2023-05-09 | -$17.64M derived: sum of 2 quarters · filed 2024-04-01 | -$15.58M derived: sum of 3 quarters · filed 2024-04-01 | -$8.57M derived: sum of 4 quarters · filed 2024-04-01 | |||
| 2021-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $6.32M derived: sum of 2 quarters · filed 2024-04-01 | $13.33M derived: sum of 3 quarters · filed 2024-04-01 | $34.31M 10-K · filed 2024-04-01 | |||
| 2021-09-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $9.07M derived: sum of 2 quarters · filed 2022-11-09 | $30.06M 10-Q · filed 2022-11-09 | -$3.48M derived: sum of 4 quarters · filed 2023-03-13 | |||
| 2021-06-30 | $7.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $28.00M 10-Q · filed 2022-08-09 | -$5.54M derived: sum of 3 quarters · filed 2023-03-13 | $16.06M derived: sum of 4 quarters · filed 2023-03-13 | |||
| 2021-03-31 | $20.98M 10-Q · filed 2022-05-10 | -$12.55M derived: sum of 2 quarters · filed 2023-03-13 | $9.05M derived: sum of 3 quarters · filed 2023-03-13 | $709.00K derived: sum of 4 quarters · filed 2023-03-13 | |||
| 2020-12-31 | -$33.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$11.94M derived: sum of 2 quarters · filed 2023-03-13 | -$20.28M derived: sum of 3 quarters · filed 2023-03-13 | -$31.34M 10-K · filed 2023-03-13 | |||
| 2020-09-30 | $21.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $13.26M derived: sum of 2 quarters · filed 2021-11-09 | $2.19M 10-Q · filed 2021-11-09 | $7.45M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | -$8.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$19.41M 10-Q · filed 2021-08-09 | -$14.15M derived: sum of 3 quarters · filed 2022-03-01 | -$12.73M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | -$11.07M 10-Q · filed 2021-05-10 | -$5.81M derived: sum of 2 quarters · filed 2022-03-01 | -$4.40M derived: sum of 3 quarters · filed 2022-03-01 | -$601.00K derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | $5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $6.67M derived: sum of 2 quarters · filed 2022-03-01 | $10.47M derived: sum of 3 quarters · filed 2022-03-01 | $12.37M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $5.21M derived: sum of 2 quarters · filed 2020-11-09 | $7.11M 10-Q · filed 2020-11-09 | $27.63M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | $3.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $5.70M 10-Q · filed 2020-08-10 | $26.22M derived: sum of 3 quarters · filed 2021-03-01 | $26.99M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | $1.90M 10-Q · filed 2020-05-11 | $22.42M derived: sum of 2 quarters · filed 2021-03-01 | $23.19M derived: sum of 3 quarters · filed 2021-03-01 | $24.54M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | $20.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $21.29M derived: sum of 2 quarters · filed 2021-03-01 | $22.64M derived: sum of 3 quarters · filed 2021-03-01 | $5.67M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $768.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $2.12M derived: sum of 2 quarters · filed 2019-11-12 | -$14.85M 10-Q · filed 2019-11-12 | -$22.27M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$15.62M 10-Q · filed 2019-08-08 | -$23.04M derived: sum of 3 quarters · filed 2020-03-02 | -$17.55M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-03-31 | -$16.96M 10-Q · filed 2019-05-09 | -$24.39M derived: sum of 2 quarters · filed 2020-03-02 | -$18.89M derived: sum of 3 quarters · filed 2020-03-02 | -$13.30M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2017-12-31 | -$7.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$1.93M derived: sum of 2 quarters · filed 2020-03-02 | $3.66M derived: sum of 3 quarters · filed 2020-03-02 | $5.11M 10-K · filed 2020-03-02 | |||
| 2017-09-30 | $5.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $11.09M derived: sum of 2 quarters · filed 2018-11-08 | $12.53M 10-Q · filed 2018-11-08 | $14.11M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-06-30 | $5.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $7.04M 10-Q · filed 2018-08-09 | $8.62M derived: sum of 3 quarters · filed 2019-03-01 | $10.27M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-03-31 | $1.44M 10-Q · filed 2018-05-10 | $3.02M derived: sum of 2 quarters · filed 2019-03-01 | $4.67M derived: sum of 3 quarters · filed 2019-03-01 | $6.83M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $3.23M derived: sum of 2 quarters · filed 2019-03-01 | $5.39M derived: sum of 3 quarters · filed 2019-03-01 | $5.52M 10-K · filed 2019-03-01 | |||
| 2016-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $3.81M derived: sum of 2 quarters · filed 2017-11-09 | $3.94M 10-Q · filed 2017-11-09 | $7.95M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $2.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $2.29M 10-Q · filed 2017-08-08 | $6.30M derived: sum of 3 quarters · filed 2018-03-01 | $5.74M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | $129.00K 10-Q · filed 2017-05-10 | $4.14M derived: sum of 2 quarters · filed 2018-03-01 | $3.58M derived: sum of 3 quarters · filed 2018-03-01 | $6.11M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $3.45M derived: sum of 2 quarters · filed 2018-03-01 | $5.98M derived: sum of 3 quarters · filed 2018-03-01 | $6.13M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | -$561.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.97M derived: sum of 2 quarters · filed 2016-11-09 | $2.12M 10-Q · filed 2016-11-09 | $2.13M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | $2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $2.68M 10-Q · filed 2016-08-09 | $2.69M derived: sum of 3 quarters · filed 2017-03-16 | $2.82M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | $146.00K 10-Q · filed 2016-05-10 | $157.00K derived: sum of 2 quarters · filed 2017-03-16 | $286.00K derived: sum of 3 quarters · filed 2017-03-16 | $50.00K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $140.00K derived: sum of 2 quarters · filed 2017-03-16 | -$96.00K derived: sum of 3 quarters · filed 2017-03-16 | $13.00K 10-K · filed 2017-03-16 | |||
| 2014-09-30 | $129.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$107.00K derived: sum of 2 quarters · filed 2015-11-09 | $2.00K 10-Q · filed 2015-11-09 | -$500.00K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-06-30 | -$236.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$127.00K 10-Q · filed 2015-08-10 | -$629.00K derived: sum of 3 quarters · filed 2016-03-15 | -$463.00K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-03-31 | $109.00K 10-Q · filed 2015-05-11 | -$393.00K derived: sum of 2 quarters · filed 2016-03-15 | -$227.00K derived: sum of 3 quarters · filed 2016-03-15 | -$1.51M derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2013-12-31 | -$502.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$336.00K derived: sum of 2 quarters · filed 2016-03-15 | -$1.62M derived: sum of 3 quarters · filed 2016-03-15 | -$1.55M 10-K · filed 2016-03-15 | |||
| 2013-09-30 | $166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$1.12M derived: sum of 2 quarters · filed 2014-11-10 | -$1.05M 10-Q · filed 2014-11-10 | $414.00K derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2013-06-30 | -$1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$1.22M 10-Q · filed 2014-08-11 | $248.00K derived: sum of 3 quarters · filed 2015-03-16 | -$52.00K derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2013-03-31 | $69.00K 10-Q · filed 2014-05-12 | $1.54M derived: sum of 2 quarters · filed 2015-03-16 | $1.24M derived: sum of 3 quarters · filed 2015-03-16 | $353.00K derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2012-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $1.17M derived: sum of 2 quarters · filed 2015-03-16 | $284.00K derived: sum of 3 quarters · filed 2015-03-16 | $1.06M 10-K · filed 2015-03-16 | |||
| 2012-09-30 | -$300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$1.18M derived: sum of 2 quarters · filed 2013-11-07 | -$408.00K 10-Q · filed 2013-11-07 | -$344.00K derived: sum of 4 quarters · filed 2014-03-13 | |||
| 2012-06-30 | -$883.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$108.00K 10-Q · filed 2013-08-09 | -$44.00K derived: sum of 3 quarters · filed 2014-03-13 | -$1.73M derived: sum of 4 quarters · filed 2014-03-13 | |||
| 2012-03-31 | $775.00K 10-Q · filed 2013-05-09 | $839.00K derived: sum of 2 quarters · filed 2014-03-13 | -$848.00K derived: sum of 3 quarters · filed 2014-03-13 | -$1.29M derived: sum of 4 quarters · filed 2014-03-13 | |||
| 2011-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$1.62M derived: sum of 2 quarters · filed 2014-03-13 | -$2.07M derived: sum of 3 quarters · filed 2014-03-13 | -$2.25M 10-K · filed 2014-03-13 | |||
| 2011-09-30 | -$1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$2.13M derived: sum of 2 quarters · filed 2012-11-09 | -$2.32M 10-Q · filed 2012-11-09 | -$1.34M derived: sum of 4 quarters · filed 2013-03-18 | -$2.14M 10-Q · filed 2011-11-08 | ||
| 2011-06-30 | -$447.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$631.00K 10-Q · filed 2012-08-07 | $348.00K derived: sum of 3 quarters · filed 2013-03-18 | -$87.00K derived: sum of 4 quarters · filed 2013-03-18 | -$452.00K 10-Q · filed 2011-08-09 | ||
| 2011-03-31 | -$184.00K 10-Q · filed 2012-05-10 | $795.00K derived: sum of 2 quarters · filed 2013-03-18 | $360.00K derived: sum of 3 quarters · filed 2013-03-18 | ||||
| 2010-12-31 | $979.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $544.00K derived: sum of 2 quarters · filed 2013-03-18 | $1.23M 10-K · filed 2013-03-18 | ||||
| 2010-09-30 | -$435.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $252.00K 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | $687.00K 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $41.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |